skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Neuropeptide Y level in paraventricular nucleus of experimental diabetic rats: correlation with sympathetic activity and body weight

Original Research

(1426) Views  (394) Full article downloads

Authors: Pallab K Ganguly

Published Date September 2010 Volume 2010:3 Pages 321 - 325
DOI: http://dx.doi.org/10.2147/IJGM.S7749

Pallab K Ganguly
College of Medicine, Alfaisal University, Riyadh, Kingdom of Saudi Arabia

Abstract: Neuropeptide Y (NPY), colocalized with norepinephrine neuron, is known to modulate sympathetic activity and feeding behavior. Although experimental type 1 diabetes has increased sympathetic activity at the early part of the disease process, little effort was made so far to understand the correlation between NPY level in the hypothalamus and sympathetic activity in diabetes. Male Sprague Dawley rats were made diabetic by a single injection of streptozotocin (65 mg/kg body weight, IV). The animals were then studied after 2, 4, and 8 weeks. Control animals received only citrate vehicle. In an effort to clarify the modulatory effect of NPY at the early stage of diabetes, the paraventricular nucleus (PVN) of hypothalamus was sampled by microdialysis for NPY and norepinephrine level. While NPY level was increased immediately within 2 weeks (along with feeding behavior), norepinephrine level was increased only after 8 weeks following injection of streptozotocin. The animals lost significant weight. These results are interpreted to mean that a strong correlation exists between the feeding behavior and NPY level in PVN. Since NPY is known to inhibit sympathetic activity it is possible that NPY receptors are down-regulated following diabetes. The higher level of norepinephrine indicating higher sympathetic activity did not allow the animals to gain weight. In addition, controversy exists regarding pleiotropic activities of NPY related to the feeding behavior of these animals.

Keywords: streptozotocin-induced diabetes, increased sympathetic activity, feeding behavior, down-regulation of NPY receptors






Readers of this article also read:

Mortality following acute medical admission in Denmark: a feasibility study
The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance?
Sex ratio of newborn infants born to pregnant women with severe chronic constipation
Update on transfusion solutions during surgery: review of hydroxyethyl starches 130/0.4
Positive predictive value and impact of misdiagnosis of a heart failure diagnosis in administrative registers among patients admitted to a University Hospital cardiac care unit
Types of neural guides and using nanotechnology for peripheral nerve reconstruction
Low energy nanoemulsification to design veterinary controlled drug delivery devices
Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial
Real-time electrical measurement of L929 cellular spontaneous and synchronous oscillation
Aripiprazole in the acute and maintenance phase of bipolar I disorder
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University